Information for Patient Controlled Analgesia Device

July 4, 2019 updated by: Tuğba Karaman

The Effect of Visual and Written Information Tools on Patient Controlled Analgesia Device Usage

This study is aimed to show the effect of information method on properly usage of the patient controlled analgesia(PCA) device

Study Overview

Detailed Description

Postoperative pain is still a challenge for anesthesiologist. Patient controlled analgesia is an effective method for postoperative pain management. However, most of the patient can not use the device properly. The important cause of inabilities about device usage is insufficient information.In the patient information, visual, oral or written communication methods can be chosen. However, which method is suitable for our patient group is not clear.This study is aimed to show the effect of information method on properly usage of the patient controlled analgesia(PCA) device

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Tokat, Merkez, Turkey, 60100
        • Gaziosmanpasa University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • informed consent
  • Elective hysterectomy

Exclusion Criteria:

  • Opioid abuse or Chronic opioid usage
  • opioid allergy
  • obesity(BMI>30)
  • psychiatric disease
  • more than American Anesthesiologist Score 2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: visual
The video about patient controlled analgesia device (PCA) usage will shown to the patients via notebook.
The video about PCA usage
Experimental: written
The written form which include the same knowledge will give to the patient for reading.
The written form which include PCA usage information.
Other: control
The anesthesiologist will describe the PCA usage as in the routine care to the control group patients.
The routine description about PCA usage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Score
Time Frame: At postoperative 24th hours.
Numeric rating scale (0 to 10) will be used for postoperative pain score
At postoperative 24th hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative analgesic consumption
Time Frame: Up to the postoperative 24th hours.
Total opioid dosage will be recorded
Up to the postoperative 24th hours.
PCA device usage
Time Frame: During postoperative 24 hours
The number of demand dose
During postoperative 24 hours
PCA device demand dose duration
Time Frame: During postoperative 24hours
The duration of the patients' demanding dose
During postoperative 24hours
Patient's satisfaction
Time Frame: At the postoperative 24th hours
The numeric rating scale (0 to 10) will be used. In this scale 0 will be the worst, 10 will be the best satisfaction.
At the postoperative 24th hours
The change of the postoperative pain score
Time Frame: Up to the postoperative 24th hours.
Numeric rating scale (0 to 10) will be used to evaluate the pain score. The change in this score during postoperative 24 hours will be calculated.(the first score will be extracted from the last score)
Up to the postoperative 24th hours.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay hospital
Time Frame: Up to the postoperative 10 days
Number of the day that patients stay at hospital will be recorded.
Up to the postoperative 10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Serkan Karaman, MD, Gaziosmanpasa University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Actual)

June 20, 2019

Study Completion (Actual)

June 21, 2019

Study Registration Dates

First Submitted

January 11, 2019

First Submitted That Met QC Criteria

January 16, 2019

First Posted (Actual)

January 17, 2019

Study Record Updates

Last Update Posted (Actual)

July 8, 2019

Last Update Submitted That Met QC Criteria

July 4, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • pcı

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Care

Clinical Trials on video

3
Subscribe